Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|June 6, 2008
New targets for therapy of sarcomaJohn M Magenau, Scott M Schuetze
Blood Advances|October 4, 2021
Type 1 interferon to prevent leukemia relapse after allogeneic transplantationJohn M Magenau, Dan Peltier, Mary Riwes, et al.
Blood Advances|April 8, 2025
PD-1 Inhibition for Relapse after Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic SyndromeJohn M Magenau, David G Frame, Mary Mansour Riwes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomesLawrence Chang, David Frame, Thomas Braun, et al.
Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Blood|January 21, 2021
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trialEphraim J Fuchs, Paul V O'Donnell, Mary Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
Pageof 2